Literature DB >> 12457862

A mouse model of proliferative vitreoretinopathy induced by dispase.

M Valeria Cantó Soler1, Juan E Gallo, Ricardo A Dodds, Angela M Suburo.   

Abstract

A proliferative vitreoretinopathy-like condition induced by intravitreal dispase injection in C57BL/6J mice was studied using ophthalmoscopic and histochemical procedures. The frequency of intravitreal hemorrhage, intravitreal spots, retinal folds and epiretinal membranes was scored by ophthalmoscopic examination at 1, 2, 4, 6 and 8 weeks after the injection. Intravitreal spots corresponded to free cells exhibiting F4/80 immunoreactivity, a macrophage/microglial marker. Retinal folds always appeared before an epiretinal membrane could be observed. Dispase-injected eyes always showed a much higher frequency of folds and membranes than saline-injected eyes. Folds and membranes appeared earlier and were more extensive in the presence of intravitreal hemorrhage than in its absence. Müller retinal cells exhibited significant changes in glial fibrillary acidic protein-immunoreactivity. This was absent in normal Müller cells but, in dispase-injected animals, it was expressed in radial processes at the site of retinal folds, later extending to the whole retina. Both epi- and subretinal membranes contained cells probably derived from Müller cells, since they exhibited co-localization of glial fibrillary acidic protein- and glutamine synthase immunoreactivities. F4/80 was also present in numerous cells within the retina, epi- and subretinal membranes. By contrast, the retinal pigment epithelium cell marker RPE65 was restricted to subretinal membranes. It can be concluded that dispase induced a proliferative vitreoretinopathy-like condition in mice, with a strong contribution of macrophage- and glial-derived cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12457862     DOI: 10.1006/exer.2002.2031

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  14 in total

1.  Nonsteroid anti-inflammatory therapy suppresses the development of proliferative vitreoretinopathy more effectively than a steroid one.

Authors:  Marina V Tikhonovich; Aleksei K Erdiakov; Svetlana A Gavrilova
Journal:  Int Ophthalmol       Date:  2017-06-21       Impact factor: 2.031

Review 2.  Involvement of Müller glial cells in epiretinal membrane formation.

Authors:  Andreas Bringmann; Peter Wiedemann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-05-05       Impact factor: 3.117

3.  Notch signaling modulates proliferative vitreoretinopathy via regulating retinal pigment epithelial-to-mesenchymal transition.

Authors:  Jingjing Zhang; Gongqiang Yuan; Muchen Dong; Ting Zhang; Gao Hua; Qingjun Zhou; Weiyun Shi
Journal:  Histochem Cell Biol       Date:  2016-09-07       Impact factor: 4.304

4.  Blockade of endothelinergic receptors prevents development of proliferative vitreoretinopathy in mice.

Authors:  María Iribarne; Liliana Ogawa; Vanesa Torbidoni; Cristian M Dodds; Ricardo A Dodds; Angela M Suburo
Journal:  Am J Pathol       Date:  2008-02-29       Impact factor: 4.307

5.  The inhibitory effect of small interference RNA protein kinase C-alpha on the experimental proliferative vitreoretinopathy induced by dispase in mice.

Authors:  Qianying Gao; Wencong Wang; Yuqing Lan; Xiaoqing Chen; Wei Yang; Yongguang Yuan; Juan Tan; Yao Zong; Zhaoxin Jiang
Journal:  Int J Nanomedicine       Date:  2013-04-19

6.  Ocular pathogenesis and immune reaction after intravitreal dispase injection in mice.

Authors:  Juan Tan; Yaqin Liu; Wei Li; Qianying Gao
Journal:  Mol Vis       Date:  2012-04-07       Impact factor: 2.367

7.  Assessment of the innate and adaptive immune system in proliferative vitreoretinopathy.

Authors:  W Zhang; J Tan; Y Liu; W Li; Q Gao; P V Lehmann
Journal:  Eye (Lond)       Date:  2012-03-30       Impact factor: 3.775

8.  Substance P prevents development of proliferative vitreoretinopathy in mice by modulating TNF-α.

Authors:  Kyungsang Yoo; Bo Kwon Son; Suna Kim; Youngsook Son; Seung-Young Yu; Hyun Sook Hong
Journal:  Mol Vis       Date:  2017-12-13       Impact factor: 2.367

9.  The proteomic profile of a mouse model of proliferative vitreoretinopathy.

Authors:  Bernadett Márkus; Zsuzsanna Pató; Zsolt Sarang; Réka Albert; József Tőzsér; Goran Petrovski; Éva Csősz
Journal:  FEBS Open Bio       Date:  2017-06-29       Impact factor: 2.693

10.  The impact of octreotide in experimental proliferative vitreoretinopathy.

Authors:  Ozge Evren; Burak Turgut; Ulku Celiker; Kadir Ates
Journal:  Indian J Ophthalmol       Date:  2013-03       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.